Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NORS for Mild COVID-19
NCT04443868Phase 2Withdrawn
- Sponsor
- SaNOtize
- Start
- Jan 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Phase 2, randomised, double-blind trial of Nitric oxide patch (Fundación Cardiovascular de Colombia) in coronavirus disease 2019 (COVID-19), sponsored by SaNOtize. Primary endpoint: Duration of COVID-19 viral infectivity at 6 days. Planned start Jan 2021; status: withdrawn.
02
Drugs
Nitric oxide patch (Fundación Cardiovascular de Colombia)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04443868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04443868.